Therefore, these results were further validated by measuring endogenous MBNL1 protein levels in ALS patient lymphoblastoid cells; no differences were observed compared with control cells (Supplementary Fig. 6d). The gene discussed is MBNL1; the disease is amyotrophic lateral sclerosis.